Public Profile

Hualan Bio

Hualan Bio, officially known as Hualan Biological Engineering Inc., is a leading biotechnology company headquartered in China (CN). Established in 1992, Hualan Bio has made significant strides in the biopharmaceutical industry, focusing on the research, development, and production of vaccines and diagnostic reagents. With major operational regions across Asia and expanding globally, the company has positioned itself as a key player in public health. Hualan Bio's core products include a range of human and animal vaccines, as well as innovative diagnostic solutions that stand out for their quality and efficacy. The company has achieved notable milestones, including several national and international certifications, reinforcing its commitment to safety and excellence. As a pioneer in the biotechnology sector, Hualan Bio continues to contribute to advancements in healthcare, solidifying its reputation as a trusted name in the industry.

DitchCarbon Score

How does Hualan Bio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

12

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Hualan Bio's score of 12 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

10%

Let us know if this data was useful to you

Hualan Bio's reported carbon emissions

Hualan Bio, headquartered in China (CN), currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is challenging to assess their climate impact or commitments. However, the company may still be engaged in various sustainability initiatives typical within the biotechnology sector. As the industry increasingly focuses on reducing carbon footprints, Hualan Bio's future commitments and strategies will be crucial in aligning with global climate goals. Further information on their climate actions would be beneficial to understand their role in addressing climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hualan Bio's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Hualan Bio is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hualan Bio is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Baxter

US
Medical, precision and optical instruments, watches and clocks (33)
Updated about 3 hours ago

Grifols

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated about 3 hours ago

China National Biotec Group Company Limited

CN
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

CSL Behring (Australia) Pty Ltd

AU
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Sinco Pharma

CN
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers